Marc Erhardt

Title: Innovations by Marc Erhardt

Introduction

Marc Erhardt is a notable inventor based in Wolfenbuttel, Germany. He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in developing immunogenic compositions that have potential applications in cancer treatment.

Latest Patents

Marc Erhardt holds a patent for an immunogenic composition that includes a mutated strain with specific mutations in flagellin II genes, such as the fliF gene. This invention also encompasses additional mutations in genes like aroA, IpxR, pagP, pagL, ydiV, and optionally eptA and arnT. The patent outlines a method for producing outer membrane vesicles (OMVs) from this strain, which can be used as a transport moiety or as part of an immunogenic composition, such as a vaccine or immunotherapy platform, particularly for treating cancer.

Career Highlights

Marc Erhardt is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts his research. His work has been instrumental in advancing the understanding of immunogenic compositions and their applications in therapeutic treatments.

Collaborations

He collaborates with esteemed colleagues, including Sebastian Felgner and Dino Kocijancic, to further enhance the impact of his research in the field of immunology.

Conclusion

Marc Erhardt's innovative contributions to immunology through his patented work demonstrate his commitment to advancing medical science. His research holds promise for developing effective treatments for cancer, showcasing the importance of innovation in healthcare.